Search for: "EC et al v. DR et al"
Results 1 - 9
of 9
Sorted by Relevance
|
Sort by Date
19 Mar 2015, 4:57 pm
(D.I. 535)Footnote 6 is relevant to Teva v. [read post]
6 Aug 2015, 5:09 am
In addition to the key case of Rottmann v Freistaat Bayern [2010] ECR I-1449 numerous other authorities such as Kaur [2001] All ER (EC) 250, McCarthy [2011] All ER (EC) 729 Zambrano [2011] ECR I-1177 and Dereci [2011] ECR I-11315 were analysed and applied to his case. [read post]
13 Jun 2011, 4:14 am
INVENTIO AG et al. [read post]
8 May 2009, 9:00 am
Canada US targets Canada over copyright in Special 301 Report (Michael Geist) (Excess Copyright) (Michael Geist) (Michael Geist) (Michael Geist) (Michael Geist) (Michael Geist) (Michael Geist) (Ars Technica) (At Last... the 1709 Copyright Blog) (Michael Geist) Federal Court awards $250,000 to Microsoft over sale of two computers with unauthorised copies of Microsoft software: Microsoft v PC Village et al (Excess Copyright) CIRA: Complaint dismissed, costs… [read post]
27 Jun 2008, 10:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Court reconsidering baseless ‘making available’ theory in file-sharing case Capitol Records v Jammie Thomas; amicus briefs from, MPAA, PFF: (Electronic Frontier Foundation), (Electronic Fontier Foundation), (Techdirt), (Ars Technica), (Patry Copyright Blog), (Patry Copyright Blog) ICANN approves rules allowing brands to be… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
2 Aug 2010, 11:15 am
Vol. 2, No. 22, August 2, 2010 The following is a summary review of articles from all over the nation concerning environmental law settlements, decisions, regulatory actions and lawsuits filed during the past week. [read post]
